Skip to main content
main-content

Head and neck cancer

15-05-2018 | Head and neck cancer | News | Article

HPV positivity may improve survival in some nonoropharyngeal head and neck cancers

Human papillomavirus positivity is associated with improved survival in patients with head and neck cancer at four of six subsites in the upper aerodigestive tract, US study findings indicate.

Source:

JAMA Otolaryngol Head Neck Surg 2018; Advance online publication

04-05-2018 | Oncology | News | Article

In other news

This month we bring you a round-up of four trials investigating nivolumab in diverse tumors, including non-small-cell lung cancer, Hodgkin lymphoma, and nasopharyngeal carcinoma. Read on to find out more.

06-04-2018 | Oncology | News | Article

In other news

In this month’s roundup, we cover topics including laboratory eligibility criteria as a potential barrier to clinical participation and the impact of cognitive dysfunction on survival in patients with hematologic cancers. Read on to find out more.

27-03-2018 | Head and neck cancer | News | Article

No benefit of adding chemotherapy to postop radiation in cutaneous SCCHN

Phase III trial findings suggest that the addition of concomitant chemotherapy to postoperative radiotherapy does not improve the outcomes of patients with high-risk cutaneous squamous cell carcinoma of the head and neck.

Source:

J Clin Oncol 2018; Advance online publication

15-03-2018 | Head and neck cancer | News | Article

News in brief

High odds of opioid prescriptions for head and neck cancer

The likelihood of being prescribed opioids is greater for patients with head and neck cancer than for those with lung or colon cancer, findings indicate.

15-02-2018 | Head and neck cancer | News | Article

News in brief

Educational gap exposed on HPV link to head and neck cancer

A survey of New York state medical students suggests many are unaware of the link between human papillomavirus infection and the risk for head and neck cancer.

image credits